EMBL-EBI | Chemical Biology | ChEBI

Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search

CHEBI:62671 - β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-[α-L-Fuc-(1→2)-β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer

ChEBI IDCHEBI:62671
ChEBI Nameβ-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-[α-L-Fuc-(1→2)-β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer
Stars
ASCII Namebeta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
DefinitionA glycononaosylceramide consisting of a branched nonasaccharide made up from four galactose residues, three N-acetylglucosamine residues, one fucosyl residue and one glucose residue, which at the reducing end is attached to the ceramide portion via a β-linkage.
Last Modified27 January 2016
SubmitterSteve
DownloadsMolfile
FormulaC79H135N4O47R
Net Charge0
Average Mass (excl. R groups)1892.916
Monoisotopic Mass (excl. R groups)1891.82966
SMILES*C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]6O)[C@H](O)[C@H]5NC(C)=O)[C@H](O)[C@H](O[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5NC(C)=O)[C@H]4O)[C@H](O)[C@H]3NC(C)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC
Species of MetaboliteComponentSourceComments
Mus musculus (ncbitaxon:10090) - PubMed (19425150) Source: BioModels - MODEL1507180067
Roles Classification
Biological Role:
mouse metabolite  Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
ChEBI Ontology
Outgoing Relation(s)
β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-[α-L-Fuc-(1→2)-β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:62671) has role mouse metabolite (CHEBI:75771)
β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-[α-L-Fuc-(1→2)-β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:62671) is a fucosyl oligoglycosylceramide (CHEBI:24121)
β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-[α-L-Fuc-(1→2)-β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:62671) is a glycononaosylceramide (CHEBI:36643)
IUPAC Name 
N-[(2S,3R,4E)-1-{[α-L-galactopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→6)-[β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)]-β-D-galactopyranosyl-(→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide
Synonyms  Source
βGal→4βGlcNAc→3(αFuc→2βGal→4βGlcNAc→6)β-Gal→4βGlcNAc→3βGal→4βGlc→CerChEBI
β-D-Galp-(1→4)-β-D-GlcpNAc-(1→3)-[α-L-Fucp-(1→2)-β-D-Galp-(1→4)-β-D-GlcpNAc-(1→6)]-β-D-Galp-(1→4)-β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-β-D-Glcp-CerChEBI
β-D-Galp-(1→4)-β-D-GlcpNAc-(1→3)-[α-L-Fucp-(1→2)-β-D-Galp-(1→4)-β-D-GlcpNAc-(1→6)]-β-D-Galp-(1→4)-β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-CerChEBI
β-Gal-(1→4)-β-GlcNAc-(1→3)-[α-Fuc-(1→2)-β-Gal-(1→4)-β-GlcNAc-(1→6)]-β-Gal-(1→4)-β-GlcNAc-(1→3)-β-Gal-(1→4)-β-Glc-(1↔1')-CerChEBI
β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-[α-L-Fuc-(1→2)-β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-CerChEBI
β-Gal-(1→4)-β-GlcNAc-(1→3)-[α-Fuc-(1→2)-β-Gal-(1→4)-β-GlcNAc-(1→6)]-β-Gal-(1→4)-β-GlcNAc-(1→3)-β-Gal-(1→4)-β-Glc-CerChEBI
Manual XrefsDatabases
G10511KEGG GLYCAN
Citations